December 10, 2024: Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two significant milestones, strengthening its position in international markets. The company has acquired approval from Brazil’s health authority, ANVISA (Agência Nacional de Vigilância Sanitária), for Esketamine Hydrochloride, which is a major step in growing its product range in Brazil and the rest of […]
The post Supriya Lifescience Expands with Esketamine Approval and Atorvastatin Filing first appeared on Business News Week.